1 Min Read
Dec 8 (Reuters) - Roche Holding Ag
* Says roche announces european approval of venclyxto for people with hard-to-treat chronic lymphocytic leukaemia Further company coverage: (Reporting By Zurich newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.